Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study

Respiratory Research

Table 2 Types of inhaled corticosteroids used by the COPD population. Reference patients did not use ICS

Variable	COPD patients with lung function data (N = 6623)^a
Types of ICS, n (%)
Budesonide	2317 (71.5)
Fluticasone propionate	236 (7.3)
Budesonide/fluticasone propionate^b	655 (20.2)
Other	30 (0.9)

^aNo ICS n = 3385; ^bIncludes patients that switched from budesonide to fluticasone propionate and fluticasone propionate to budesonide during the study period, as well as a few patients that were using both budesonide and fluticasone propionate at the same time
COPD chronic obstructive pulmonary disease, ICS inhaled corticosteroids

ISSN: 1465-993X